Home > > > Report Detail

Covid-19 Impact on Global Point-of-Care or Rapid Testing Market Insights, Forecast to 2026

Publisher Name :
Date: 06-May-2020
No. of pages: 185
Inquire Before Buying

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Point-of-Care or Rapid Testing market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Point-of-Care or Rapid Testing industry.

Based on our recent survey, we have several different scenarios about the Point-of-Care or Rapid Testing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Point-of-Care or Rapid Testing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-Care or Rapid Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-Care or Rapid Testing market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Point-of-Care or Rapid Testing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Production and Pricing Analyses

Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Point-of-Care or Rapid Testing market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Point-of-Care or Rapid Testing market has been provided based on region.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Point-of-Care or Rapid Testing market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Point-of-Care or Rapid Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-Care or Rapid Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-Care or Rapid Testing market.

The following manufacturers are covered in this report:

- Roche

- Abbott

- Johnson & Johnson

- Siemens Healthcare

- Danaher

- Ascensia

- Bio-Rad Laboratories

- BioMerieux

- ARKRAY

- Nova Biomedical

- Trividia Health

- Quidel

- Accriva

- OraSure Technologies

- Helena Laboratories

- A. Menarini Diagnostics

- Abaxis (Zoetis)

- Ortho Clinical Diagnostics

- Phamatech

- Chembio Diagnostics

- Sinocare

- Wondfo

- Yuwell

- Runbio

- KHB

- Wuhan EasyDiagnosis Biomedicine

- DAAN GENE

Point-of-Care or Rapid Testing Breakdown Data by Type

- Blood Glucose Testing

- Infectious Diseases Testing

- Cardiac Markers Testing

- Coagulation Testing

- Pregnancy and Fertility Testing

- Blood Gas/Electrolytes Testing

- Urinalysis Testing

- Others

Point-of-Care or Rapid Testing Breakdown Data by Application

- Clinics

- Hospitals

- Laboratory

- Others

Covid-19 Impact on Global Point-of-Care or Rapid Testing Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Point-of-Care or Rapid Testing Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Point-of-Care or Rapid Testing Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Point-of-Care or Rapid Testing Market Size Growth Rate by Type
1.4.2 Blood Glucose Testing
1.4.3 Infectious Diseases Testing
1.4.4 Cardiac Markers Testing
1.4.5 Coagulation Testing
1.4.6 Pregnancy and Fertility Testing
1.4.7 Blood Gas/Electrolytes Testing
1.4.8 Urinalysis Testing
1.4.9 Others
1.5 Market by Application
1.5.1 Global Point-of-Care or Rapid Testing Market Size Growth Rate by Application
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Laboratory
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Point-of-Care or Rapid Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Point-of-Care or Rapid Testing Industry
1.6.1.1 Point-of-Care or Rapid Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Point-of-Care or Rapid Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Point-of-Care or Rapid Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Point-of-Care or Rapid Testing Market Size Estimates and Forecasts
2.1.1 Global Point-of-Care or Rapid Testing Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Point-of-Care or Rapid Testing Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Point-of-Care or Rapid Testing Production Estimates and Forecasts 2015-2026
2.2 Global Point-of-Care or Rapid Testing Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Point-of-Care or Rapid Testing Manufacturers Geographical Distribution
2.4 Key Trends for Point-of-Care or Rapid Testing Markets & Products
2.5 Primary Interviews with Key Point-of-Care or Rapid Testing Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Point-of-Care or Rapid Testing Manufacturers by Production Capacity
3.1.1 Global Top Point-of-Care or Rapid Testing Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Point-of-Care or Rapid Testing Manufacturers by Production (2015-2020)
3.1.3 Global Top Point-of-Care or Rapid Testing Manufacturers Market Share by Production
3.2 Global Top Point-of-Care or Rapid Testing Manufacturers by Revenue
3.2.1 Global Top Point-of-Care or Rapid Testing Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Point-of-Care or Rapid Testing Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Point-of-Care or Rapid Testing Revenue in 2019
3.3 Global Point-of-Care or Rapid Testing Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care or Rapid Testing Production by Regions
4.1 Global Point-of-Care or Rapid Testing Historic Market Facts & Figures by Regions
4.1.1 Global Top Point-of-Care or Rapid Testing Regions by Production (2015-2020)
4.1.2 Global Top Point-of-Care or Rapid Testing Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Point-of-Care or Rapid Testing Production (2015-2020)
4.2.2 North America Point-of-Care or Rapid Testing Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Point-of-Care or Rapid Testing Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Point-of-Care or Rapid Testing Production (2015-2020)
4.3.2 Europe Point-of-Care or Rapid Testing Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Point-of-Care or Rapid Testing Import & Export (2015-2020)
4.4 China
4.4.1 China Point-of-Care or Rapid Testing Production (2015-2020)
4.4.2 China Point-of-Care or Rapid Testing Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Point-of-Care or Rapid Testing Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Point-of-Care or Rapid Testing Production (2015-2020)
4.5.2 Japan Point-of-Care or Rapid Testing Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Point-of-Care or Rapid Testing Import & Export (2015-2020)
5 Point-of-Care or Rapid Testing Consumption by Region
5.1 Global Top Point-of-Care or Rapid Testing Regions by Consumption
5.1.1 Global Top Point-of-Care or Rapid Testing Regions by Consumption (2015-2020)
5.1.2 Global Top Point-of-Care or Rapid Testing Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Point-of-Care or Rapid Testing Consumption by Application
5.2.2 North America Point-of-Care or Rapid Testing Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Point-of-Care or Rapid Testing Consumption by Application
5.3.2 Europe Point-of-Care or Rapid Testing Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Point-of-Care or Rapid Testing Consumption by Application
5.4.2 Asia Pacific Point-of-Care or Rapid Testing Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Point-of-Care or Rapid Testing Consumption by Application
5.5.2 Central & South America Point-of-Care or Rapid Testing Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Point-of-Care or Rapid Testing Consumption by Application
5.6.2 Middle East and Africa Point-of-Care or Rapid Testing Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Point-of-Care or Rapid Testing Market Size by Type (2015-2020)
6.1.1 Global Point-of-Care or Rapid Testing Production by Type (2015-2020)
6.1.2 Global Point-of-Care or Rapid Testing Revenue by Type (2015-2020)
6.1.3 Point-of-Care or Rapid Testing Price by Type (2015-2020)
6.2 Global Point-of-Care or Rapid Testing Market Forecast by Type (2021-2026)
6.2.1 Global Point-of-Care or Rapid Testing Production Forecast by Type (2021-2026)
6.2.2 Global Point-of-Care or Rapid Testing Revenue Forecast by Type (2021-2026)
6.2.3 Global Point-of-Care or Rapid Testing Price Forecast by Type (2021-2026)
6.3 Global Point-of-Care or Rapid Testing Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Point-of-Care or Rapid Testing Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Point-of-Care or Rapid Testing Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Roche
8.1.1 Roche Corporation Information
8.1.2 Roche Overview and Its Total Revenue
8.1.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Roche Product Description
8.1.5 Roche Recent Development
8.2 Abbott
8.2.1 Abbott Corporation Information
8.2.2 Abbott Overview and Its Total Revenue
8.2.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Abbott Product Description
8.2.5 Abbott Recent Development
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Corporation Information
8.3.2 Johnson & Johnson Overview and Its Total Revenue
8.3.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Johnson & Johnson Product Description
8.3.5 Johnson & Johnson Recent Development
8.4 Siemens Healthcare
8.4.1 Siemens Healthcare Corporation Information
8.4.2 Siemens Healthcare Overview and Its Total Revenue
8.4.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Siemens Healthcare Product Description
8.4.5 Siemens Healthcare Recent Development
8.5 Danaher
8.5.1 Danaher Corporation Information
8.5.2 Danaher Overview and Its Total Revenue
8.5.3 Danaher Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Danaher Product Description
8.5.5 Danaher Recent Development
8.6 Ascensia
8.6.1 Ascensia Corporation Information
8.6.2 Ascensia Overview and Its Total Revenue
8.6.3 Ascensia Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Ascensia Product Description
8.6.5 Ascensia Recent Development
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Corporation Information
8.7.2 Bio-Rad Laboratories Overview and Its Total Revenue
8.7.3 Bio-Rad Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Bio-Rad Laboratories Product Description
8.7.5 Bio-Rad Laboratories Recent Development
8.8 BioMerieux
8.8.1 BioMerieux Corporation Information
8.8.2 BioMerieux Overview and Its Total Revenue
8.8.3 BioMerieux Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 BioMerieux Product Description
8.8.5 BioMerieux Recent Development
8.9 ARKRAY
8.9.1 ARKRAY Corporation Information
8.9.2 ARKRAY Overview and Its Total Revenue
8.9.3 ARKRAY Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 ARKRAY Product Description
8.9.5 ARKRAY Recent Development
8.10 Nova Biomedical
8.10.1 Nova Biomedical Corporation Information
8.10.2 Nova Biomedical Overview and Its Total Revenue
8.10.3 Nova Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Nova Biomedical Product Description
8.10.5 Nova Biomedical Recent Development
8.11 Trividia Health
8.11.1 Trividia Health Corporation Information
8.11.2 Trividia Health Overview and Its Total Revenue
8.11.3 Trividia Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Trividia Health Product Description
8.11.5 Trividia Health Recent Development
8.12 Quidel
8.12.1 Quidel Corporation Information
8.12.2 Quidel Overview and Its Total Revenue
8.12.3 Quidel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Quidel Product Description
8.12.5 Quidel Recent Development
8.13 Accriva
8.13.1 Accriva Corporation Information
8.13.2 Accriva Overview and Its Total Revenue
8.13.3 Accriva Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Accriva Product Description
8.13.5 Accriva Recent Development
8.14 OraSure Technologies
8.14.1 OraSure Technologies Corporation Information
8.14.2 OraSure Technologies Overview and Its Total Revenue
8.14.3 OraSure Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 OraSure Technologies Product Description
8.14.5 OraSure Technologies Recent Development
8.15 Helena Laboratories
8.15.1 Helena Laboratories Corporation Information
8.15.2 Helena Laboratories Overview and Its Total Revenue
8.15.3 Helena Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Helena Laboratories Product Description
8.15.5 Helena Laboratories Recent Development
8.16 A. Menarini Diagnostics
8.16.1 A. Menarini Diagnostics Corporation Information
8.16.2 A. Menarini Diagnostics Overview and Its Total Revenue
8.16.3 A. Menarini Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 A. Menarini Diagnostics Product Description
8.16.5 A. Menarini Diagnostics Recent Development
8.17 Abaxis (Zoetis)
8.17.1 Abaxis (Zoetis) Corporation Information
8.17.2 Abaxis (Zoetis) Overview and Its Total Revenue
8.17.3 Abaxis (Zoetis) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Abaxis (Zoetis) Product Description
8.17.5 Abaxis (Zoetis) Recent Development
8.18 Ortho Clinical Diagnostics
8.18.1 Ortho Clinical Diagnostics Corporation Information
8.18.2 Ortho Clinical Diagnostics Overview and Its Total Revenue
8.18.3 Ortho Clinical Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 Ortho Clinical Diagnostics Product Description
8.18.5 Ortho Clinical Diagnostics Recent Development
8.19 Phamatech
8.19.1 Phamatech Corporation Information
8.19.2 Phamatech Overview and Its Total Revenue
8.19.3 Phamatech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 Phamatech Product Description
8.19.5 Phamatech Recent Development
8.20 Chembio Diagnostics
8.20.1 Chembio Diagnostics Corporation Information
8.20.2 Chembio Diagnostics Overview and Its Total Revenue
8.20.3 Chembio Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 Chembio Diagnostics Product Description
8.20.5 Chembio Diagnostics Recent Development
8.21 Sinocare
8.21.1 Sinocare Corporation Information
8.21.2 Sinocare Overview and Its Total Revenue
8.21.3 Sinocare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 Sinocare Product Description
8.21.5 Sinocare Recent Development
8.22 Wondfo
8.22.1 Wondfo Corporation Information
8.22.2 Wondfo Overview and Its Total Revenue
8.22.3 Wondfo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.22.4 Wondfo Product Description
8.22.5 Wondfo Recent Development
8.23 Yuwell
8.23.1 Yuwell Corporation Information
8.23.2 Yuwell Overview and Its Total Revenue
8.23.3 Yuwell Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.23.4 Yuwell Product Description
8.23.5 Yuwell Recent Development
8.24 Runbio
8.24.1 Runbio Corporation Information
8.24.2 Runbio Overview and Its Total Revenue
8.24.3 Runbio Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.24.4 Runbio Product Description
8.24.5 Runbio Recent Development
8.25 KHB
8.25.1 KHB Corporation Information
8.25.2 KHB Overview and Its Total Revenue
8.25.3 KHB Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.25.4 KHB Product Description
8.25.5 KHB Recent Development
8.26 Wuhan EasyDiagnosis Biomedicine
8.26.1 Wuhan EasyDiagnosis Biomedicine Corporation Information
8.26.2 Wuhan EasyDiagnosis Biomedicine Overview and Its Total Revenue
8.26.3 Wuhan EasyDiagnosis Biomedicine Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.26.4 Wuhan EasyDiagnosis Biomedicine Product Description
8.26.5 Wuhan EasyDiagnosis Biomedicine Recent Development
8.27 DAAN GENE
8.27.1 DAAN GENE Corporation Information
8.27.2 DAAN GENE Overview and Its Total Revenue
8.27.3 DAAN GENE Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.27.4 DAAN GENE Product Description
8.27.5 DAAN GENE Recent Development
9 Production Forecasts by Regions
9.1 Global Top Point-of-Care or Rapid Testing Regions Forecast by Revenue (2021-2026)
9.2 Global Top Point-of-Care or Rapid Testing Regions Forecast by Production (2021-2026)
9.3 Key Point-of-Care or Rapid Testing Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Point-of-Care or Rapid Testing Consumption Forecast by Region
10.1 Global Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
10.2 North America Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
10.3 Europe Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
10.5 Latin America Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Point-of-Care or Rapid Testing Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Point-of-Care or Rapid Testing Sales Channels
11.2.2 Point-of-Care or Rapid Testing Distributors
11.3 Point-of-Care or Rapid Testing Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Point-of-Care or Rapid Testing Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Point-of-Care or Rapid Testing Key Market Segments in This Study
Table 2. Ranking of Global Top Point-of-Care or Rapid Testing Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Point-of-Care or Rapid Testing Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Blood Glucose Testing
Table 5. Major Manufacturers of Infectious Diseases Testing
Table 6. Major Manufacturers of Cardiac Markers Testing
Table 7. Major Manufacturers of Coagulation Testing
Table 8. Major Manufacturers of Pregnancy and Fertility Testing
Table 9. Major Manufacturers of Blood Gas/Electrolytes Testing
Table 10. Major Manufacturers of Urinalysis Testing
Table 11. Major Manufacturers of Others
Table 12. COVID-19 Impact Global Market: (Four Point-of-Care or Rapid Testing Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Point-of-Care or Rapid Testing Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Point-of-Care or Rapid Testing Players to Combat Covid-19 Impact
Table 17. Global Point-of-Care or Rapid Testing Market Size Growth Rate by Application 2020-2026 (K Units)
Table 18. Global Point-of-Care or Rapid Testing Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 19. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Point-of-Care or Rapid Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care or Rapid Testing as of 2019)
Table 21. Point-of-Care or Rapid Testing Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Point-of-Care or Rapid Testing Product Offered
Table 23. Date of Manufacturers Enter into Point-of-Care or Rapid Testing Market
Table 24. Key Trends for Point-of-Care or Rapid Testing Markets & Products
Table 25. Main Points Interviewed from Key Point-of-Care or Rapid Testing Players
Table 26. Global Point-of-Care or Rapid Testing Production Capacity by Manufacturers (2015-2020) (K Units)
Table 27. Global Point-of-Care or Rapid Testing Production Share by Manufacturers (2015-2020)
Table 28. Point-of-Care or Rapid Testing Revenue by Manufacturers (2015-2020) (Million US$)
Table 29. Point-of-Care or Rapid Testing Revenue Share by Manufacturers (2015-2020)
Table 30. Point-of-Care or Rapid Testing Price by Manufacturers 2015-2020 (USD/Unit)
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Point-of-Care or Rapid Testing Production by Regions (2015-2020) (K Units)
Table 33. Global Point-of-Care or Rapid Testing Production Market Share by Regions (2015-2020)
Table 34. Global Point-of-Care or Rapid Testing Revenue by Regions (2015-2020) (US$ Million)
Table 35. Global Point-of-Care or Rapid Testing Revenue Market Share by Regions (2015-2020)
Table 36. Key Point-of-Care or Rapid Testing Players in North America
Table 37. Import & Export of Point-of-Care or Rapid Testing in North America (K Units)
Table 38. Key Point-of-Care or Rapid Testing Players in Europe
Table 39. Import & Export of Point-of-Care or Rapid Testing in Europe (K Units)
Table 40. Key Point-of-Care or Rapid Testing Players in China
Table 41. Import & Export of Point-of-Care or Rapid Testing in China (K Units)
Table 42. Key Point-of-Care or Rapid Testing Players in Japan
Table 43. Import & Export of Point-of-Care or Rapid Testing in Japan (K Units)
Table 44. Global Point-of-Care or Rapid Testing Consumption by Regions (2015-2020) (K Units)
Table 45. Global Point-of-Care or Rapid Testing Consumption Market Share by Regions (2015-2020)
Table 46. North America Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 47. North America Point-of-Care or Rapid Testing Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 49. Europe Point-of-Care or Rapid Testing Consumption by Countries (2015-2020) (K Units)
Table 50. Asia Pacific Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 51. Asia Pacific Point-of-Care or Rapid Testing Consumption Market Share by Application (2015-2020) (K Units)
Table 52. Asia Pacific Point-of-Care or Rapid Testing Consumption by Regions (2015-2020) (K Units)
Table 53. Latin America Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 54. Latin America Point-of-Care or Rapid Testing Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East and Africa Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 56. Middle East and Africa Point-of-Care or Rapid Testing Consumption by Countries (2015-2020) (K Units)
Table 57. Global Point-of-Care or Rapid Testing Production by Type (2015-2020) (K Units)
Table 58. Global Point-of-Care or Rapid Testing Production Share by Type (2015-2020)
Table 59. Global Point-of-Care or Rapid Testing Revenue by Type (2015-2020) (Million US$)
Table 60. Global Point-of-Care or Rapid Testing Revenue Share by Type (2015-2020)
Table 61. Point-of-Care or Rapid Testing Price by Type 2015-2020 (USD/Unit)
Table 62. Global Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 63. Global Point-of-Care or Rapid Testing Consumption by Application (2015-2020) (K Units)
Table 64. Global Point-of-Care or Rapid Testing Consumption Share by Application (2015-2020)
Table 65. Roche Corporation Information
Table 66. Roche Description and Major Businesses
Table 67. Roche Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Roche Product
Table 69. Roche Recent Development
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Major Businesses
Table 72. Abbott Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Abbott Product
Table 74. Abbott Recent Development
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Major Businesses
Table 77. Johnson & Johnson Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Johnson & Johnson Product
Table 79. Johnson & Johnson Recent Development
Table 80. Siemens Healthcare Corporation Information
Table 81. Siemens Healthcare Description and Major Businesses
Table 82. Siemens Healthcare Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Siemens Healthcare Product
Table 84. Siemens Healthcare Recent Development
Table 85. Danaher Corporation Information
Table 86. Danaher Description and Major Businesses
Table 87. Danaher Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Danaher Product
Table 89. Danaher Recent Development
Table 90. Ascensia Corporation Information
Table 91. Ascensia Description and Major Businesses
Table 92. Ascensia Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Ascensia Product
Table 94. Ascensia Recent Development
Table 95. Bio-Rad Laboratories Corporation Information
Table 96. Bio-Rad Laboratories Description and Major Businesses
Table 97. Bio-Rad Laboratories Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bio-Rad Laboratories Product
Table 99. Bio-Rad Laboratories Recent Development
Table 100. BioMerieux Corporation Information
Table 101. BioMerieux Description and Major Businesses
Table 102. BioMerieux Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BioMerieux Product
Table 104. BioMerieux Recent Development
Table 105. ARKRAY Corporation Information
Table 106. ARKRAY Description and Major Businesses
Table 107. ARKRAY Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. ARKRAY Product
Table 109. ARKRAY Recent Development
Table 110. Nova Biomedical Corporation Information
Table 111. Nova Biomedical Description and Major Businesses
Table 112. Nova Biomedical Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Nova Biomedical Product
Table 114. Nova Biomedical Recent Development
Table 115. Trividia Health Corporation Information
Table 116. Trividia Health Description and Major Businesses
Table 117. Trividia Health Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Trividia Health Product
Table 119. Trividia Health Recent Development
Table 120. Quidel Corporation Information
Table 121. Quidel Description and Major Businesses
Table 122. Quidel Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Quidel Product
Table 124. Quidel Recent Development
Table 125. Accriva Corporation Information
Table 126. Accriva Description and Major Businesses
Table 127. Accriva Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Accriva Product
Table 129. Accriva Recent Development
Table 130. OraSure Technologies Corporation Information
Table 131. OraSure Technologies Description and Major Businesses
Table 132. OraSure Technologies Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. OraSure Technologies Product
Table 134. OraSure Technologies Recent Development
Table 135. Helena Laboratories Corporation Information
Table 136. Helena Laboratories Description and Major Businesses
Table 137. Helena Laboratories Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Helena Laboratories Product
Table 139. Helena Laboratories Recent Development
Table 140. A. Menarini Diagnostics Corporation Information
Table 141. A. Menarini Diagnostics Description and Major Businesses
Table 142. A. Menarini Diagnostics Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. A. Menarini Diagnostics Product
Table 144. A. Menarini Diagnostics Recent Development
Table 145. Abaxis (Zoetis) Corporation Information
Table 146. Abaxis (Zoetis) Description and Major Businesses
Table 147. Abaxis (Zoetis) Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Abaxis (Zoetis) Product
Table 149. Abaxis (Zoetis) Recent Development
Table 150. Ortho Clinical Diagnostics Corporation Information
Table 151. Ortho Clinical Diagnostics Description and Major Businesses
Table 152. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Ortho Clinical Diagnostics Product
Table 154. Ortho Clinical Diagnostics Recent Development
Table 155. Phamatech Corporation Information
Table 156. Phamatech Description and Major Businesses
Table 157. Phamatech Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Phamatech Product
Table 159. Phamatech Recent Development
Table 160. Chembio Diagnostics Corporation Information
Table 161. Chembio Diagnostics Description and Major Businesses
Table 162. Chembio Diagnostics Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Chembio Diagnostics Product
Table 164. Chembio Diagnostics Recent Development
Table 165. Sinocare Corporation Information
Table 166. Sinocare Description and Major Businesses
Table 167. Sinocare Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Sinocare Product
Table 169. Sinocare Recent Development
Table 170. Wondfo Corporation Information
Table 171. Wondfo Description and Major Businesses
Table 172. Wondfo Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Wondfo Product
Table 174. Wondfo Recent Development
Table 175. Yuwell Corporation Information
Table 176. Yuwell Description and Major Businesses
Table 177. Yuwell Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Yuwell Product
Table 179. Yuwell Recent Development
Table 180. Runbio Corporation Information
Table 181. Runbio Description and Major Businesses
Table 182. Runbio Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Runbio Product
Table 184. Runbio Recent Development
Table 185. KHB Corporation Information
Table 186. KHB Description and Major Businesses
Table 187. KHB Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 188. KHB Product
Table 189. KHB Recent Development
Table 190. Wuhan EasyDiagnosis Biomedicine Corporation Information
Table 191. Wuhan EasyDiagnosis Biomedicine Description and Major Businesses
Table 192. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 193. Wuhan EasyDiagnosis Biomedicine Product
Table 194. Wuhan EasyDiagnosis Biomedicine Recent Development
Table 195. DAAN GENE Corporation Information
Table 196. DAAN GENE Description and Major Businesses
Table 197. DAAN GENE Point-of-Care or Rapid Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 198. DAAN GENE Product
Table 199. DAAN GENE Recent Development
Table 200. Global Point-of-Care or Rapid Testing Revenue Forecast by Region (2021-2026) (Million US$)
Table 201. Global Point-of-Care or Rapid Testing Production Forecast by Regions (2021-2026) (K Units)
Table 202. Global Point-of-Care or Rapid Testing Production Forecast by Type (2021-2026) (K Units)
Table 203. Global Point-of-Care or Rapid Testing Revenue Forecast by Type (2021-2026) (Million US$)
Table 204. North America Point-of-Care or Rapid Testing Consumption Forecast by Regions (2021-2026) (K Units)
Table 205. Europe Point-of-Care or Rapid Testing Consumption Forecast by Regions (2021-2026) (K Units)
Table 206. Asia Pacific Point-of-Care or Rapid Testing Consumption Forecast by Regions (2021-2026) (K Units)
Table 207. Latin America Point-of-Care or Rapid Testing Consumption Forecast by Regions (2021-2026) (K Units)
Table 208. Middle East and Africa Point-of-Care or Rapid Testing Consumption Forecast by Regions (2021-2026) (K Units)
Table 209. Point-of-Care or Rapid Testing Distributors List
Table 210. Point-of-Care or Rapid Testing Customers List
Table 211. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 212. Key Challenges
Table 213. Market Risks
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Fifures
Figure 1. Point-of-Car
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs